What’s new in traumatic brain injury: Update on tracking, monitoring and treatment

Cesar Reis, Yuechun Wang, Onat Akyol, Wing Mann Ho, Richard Lee Applegate, Gary Stier, Robert Martin, John H. Zhang

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Traumatic brain injury (TBI), defined as an alteration in brain functions caused by an external force, is responsible for high morbidity and mortality around the world. It is important to identify and treat TBI victims as early as possible. Tracking and monitoring TBI with neuroimaging technologies, including functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), positron emission tomography (PET), and high definition fiber tracking (HDFT) show increasing sensitivity and specificity. Classical electrophysiological monitoring, together with newly established brain-on-chip, cerebral microdialysis techniques, both benefit TBI. First generation molecular biomarkers, based on genomic and proteomic changes following TBI, have proven effective and economical. It is conceivable that TBI-specific biomarkers will be developed with the  combination of systems biology and bioinformation strategies. Advances in treatment of TBI include stem cell-based and nanotechnology-based therapy, physical and pharmaceutical interventions and also new use in TBI for approved drugs which all present favorable promise in preventing and reversing TBI.

Original languageEnglish (US)
Pages (from-to)11903-11965
Number of pages63
JournalInternational Journal of Molecular Sciences
Volume16
Issue number6
DOIs
StatePublished - May 26 2015
Externally publishedYes

Fingerprint

brain damage
Brain
Monitoring
biomarkers
brain
Biomarkers
Traumatic Brain Injury
Nanotechnology
Diffusion Tensor Imaging
Systems Biology
reversing
Diffusion tensor imaging
stem cells
mortality
Physical therapy
Neuroimaging
Microdialysis
nanotechnology
Positron emission tomography
biology

Keywords

  • Biomarker
  • Electrophysiology
  • Genomic
  • Hypothermia
  • Microdialysis
  • Nano particle
  • Neuroimaging
  • Proteomic
  • Stem cell
  • Traumatic brain injury

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Computer Science Applications
  • Spectroscopy
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

What’s new in traumatic brain injury : Update on tracking, monitoring and treatment. / Reis, Cesar; Wang, Yuechun; Akyol, Onat; Ho, Wing Mann; Applegate, Richard Lee; Stier, Gary; Martin, Robert; Zhang, John H.

In: International Journal of Molecular Sciences, Vol. 16, No. 6, 26.05.2015, p. 11903-11965.

Research output: Contribution to journalArticle

Reis, Cesar ; Wang, Yuechun ; Akyol, Onat ; Ho, Wing Mann ; Applegate, Richard Lee ; Stier, Gary ; Martin, Robert ; Zhang, John H. / What’s new in traumatic brain injury : Update on tracking, monitoring and treatment. In: International Journal of Molecular Sciences. 2015 ; Vol. 16, No. 6. pp. 11903-11965.
@article{dc9ec3d965004d3a9cafd45df4422133,
title = "What’s new in traumatic brain injury: Update on tracking, monitoring and treatment",
abstract = "Traumatic brain injury (TBI), defined as an alteration in brain functions caused by an external force, is responsible for high morbidity and mortality around the world. It is important to identify and treat TBI victims as early as possible. Tracking and monitoring TBI with neuroimaging technologies, including functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), positron emission tomography (PET), and high definition fiber tracking (HDFT) show increasing sensitivity and specificity. Classical electrophysiological monitoring, together with newly established brain-on-chip, cerebral microdialysis techniques, both benefit TBI. First generation molecular biomarkers, based on genomic and proteomic changes following TBI, have proven effective and economical. It is conceivable that TBI-specific biomarkers will be developed with the  combination of systems biology and bioinformation strategies. Advances in treatment of TBI include stem cell-based and nanotechnology-based therapy, physical and pharmaceutical interventions and also new use in TBI for approved drugs which all present favorable promise in preventing and reversing TBI.",
keywords = "Biomarker, Electrophysiology, Genomic, Hypothermia, Microdialysis, Nano particle, Neuroimaging, Proteomic, Stem cell, Traumatic brain injury",
author = "Cesar Reis and Yuechun Wang and Onat Akyol and Ho, {Wing Mann} and Applegate, {Richard Lee} and Gary Stier and Robert Martin and Zhang, {John H.}",
year = "2015",
month = "5",
day = "26",
doi = "10.3390/ijms160611903",
language = "English (US)",
volume = "16",
pages = "11903--11965",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "6",

}

TY - JOUR

T1 - What’s new in traumatic brain injury

T2 - Update on tracking, monitoring and treatment

AU - Reis, Cesar

AU - Wang, Yuechun

AU - Akyol, Onat

AU - Ho, Wing Mann

AU - Applegate, Richard Lee

AU - Stier, Gary

AU - Martin, Robert

AU - Zhang, John H.

PY - 2015/5/26

Y1 - 2015/5/26

N2 - Traumatic brain injury (TBI), defined as an alteration in brain functions caused by an external force, is responsible for high morbidity and mortality around the world. It is important to identify and treat TBI victims as early as possible. Tracking and monitoring TBI with neuroimaging technologies, including functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), positron emission tomography (PET), and high definition fiber tracking (HDFT) show increasing sensitivity and specificity. Classical electrophysiological monitoring, together with newly established brain-on-chip, cerebral microdialysis techniques, both benefit TBI. First generation molecular biomarkers, based on genomic and proteomic changes following TBI, have proven effective and economical. It is conceivable that TBI-specific biomarkers will be developed with the  combination of systems biology and bioinformation strategies. Advances in treatment of TBI include stem cell-based and nanotechnology-based therapy, physical and pharmaceutical interventions and also new use in TBI for approved drugs which all present favorable promise in preventing and reversing TBI.

AB - Traumatic brain injury (TBI), defined as an alteration in brain functions caused by an external force, is responsible for high morbidity and mortality around the world. It is important to identify and treat TBI victims as early as possible. Tracking and monitoring TBI with neuroimaging technologies, including functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), positron emission tomography (PET), and high definition fiber tracking (HDFT) show increasing sensitivity and specificity. Classical electrophysiological monitoring, together with newly established brain-on-chip, cerebral microdialysis techniques, both benefit TBI. First generation molecular biomarkers, based on genomic and proteomic changes following TBI, have proven effective and economical. It is conceivable that TBI-specific biomarkers will be developed with the  combination of systems biology and bioinformation strategies. Advances in treatment of TBI include stem cell-based and nanotechnology-based therapy, physical and pharmaceutical interventions and also new use in TBI for approved drugs which all present favorable promise in preventing and reversing TBI.

KW - Biomarker

KW - Electrophysiology

KW - Genomic

KW - Hypothermia

KW - Microdialysis

KW - Nano particle

KW - Neuroimaging

KW - Proteomic

KW - Stem cell

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=84930684334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930684334&partnerID=8YFLogxK

U2 - 10.3390/ijms160611903

DO - 10.3390/ijms160611903

M3 - Article

C2 - 26016501

AN - SCOPUS:84930684334

VL - 16

SP - 11903

EP - 11965

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 6

ER -